Paul Webster. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Antipsychotic Agents/adverse effectsAntipsychotic Agents/therapeutic useDelusions/drug therapyDelusions/etiologyDrug EvaluationHallucinations/drug therapyHallucinations/etiologyHumansParkinson Disease/drug therapyParkinson Disease/psychologyPiperidines/adverse effectsPiperidines/therapeutic useUnited StatesUnited States Food and Drug AdministrationUrea/adverse effectsUrea/analogs & derivativesUrea/therapeutic use
Substances： See more » Antipsychotic AgentsPiperidinesUreapimavanserin
Year: 2018 PMID： 29739555 DOI： 10.1016/S0140-6736(18)31002-X
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321